Document Detail


Evaluation of Eslicarbazepine Acetate on Cardiac Repolarization in a Thorough QT/QTc Study.
MedLine Citation:
PMID:  21415284     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
This study investigated the effect of eslicarbazepine acetate (ESL) on cardiac repolarization in healthy adult volunteers. A randomized, placebo/active-controlled, 4-period crossover study was conducted in 67 participants. In 3 periods, participants received once-daily doses of ESL 1200 mg, ESL 2400 mg, and placebo for 5 days; in 1 period, participants received placebo on days 1 to 4 and a 400-mg moxifloxacin single dose on day 5. In each period, 24-hour 12-lead Holter monitoring was performed on days -1 (baseline) and 5. There was no clinically relevant effect of ESL 1200 mg and 2400 mg versus placebo on cardiac depolarization or repolarization as measured by the QRS or QTc intervals, respectively. Mean PR interval increased following ESL 1200 mg and 2400 mg, but there was no participant with a PR interval above the upper limit of the normal range (200 ms). The upper bound of the 95% confidence interval for the placebo-corrected change from baseline of the individually corrected QT interval (QTcI) following administration of ESL 1200 mg and ESL 2400 mg was <10 ms at every time point. Moxifloxacin caused an increase in QTcI above the 10-ms threshold for clinical significance at several time points, demonstrating assay sensitivity. It is concluded that administration of ESL 1200 mg and ESL 2400 mg did not induce a clinically significant prolongation of the QTcI interval.
Authors:
Manuel Vaz-da-Silva; Teresa Nunes; Luis Almeida; Maria J Gutierrez; Jeffrey S Litwin; Patrício Soares-da-Silva
Related Documents :
9378164 - Treatment of penile intraepithelial neoplasia (pin) with interferon alpha-2a, co2 laser...
3106584 - A phase i clinical trial of recombinant dna gamma interferon.
22151064 - Clinical sedation and bispectral index in burn children receiving gamma-hydroxybutyrate.
21542114 - Prevention of contrast-induced acute kidney injury in patients with stable chronic rena...
21205444 - Pharmacokinetics of cefovecin in squirrel monkey (saimiri sciureus), rhesus macaques (m...
18465244 - Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple th...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-17
Journal Detail:
Title:  Journal of clinical pharmacology     Volume:  -     ISSN:  1552-4604     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0366372     Medline TA:  J Clin Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
BIAL-Portela & Co.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reevaluation of Moxifloxacin Pharmacokinetics and Their Direct Effect on the QT Interval.
Next Document:  Efficacy of Antidepressants as Analgesics: A Review.